EyePoint Pharmaceuticals Inc (EYPT) Stock: A Year of Declines and Increases

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. EyePoint Pharmaceuticals Inc’s current trading price is -21.63% away from its 52-week high, while its distance from the 52-week low is 180.31%. The stock’s price range for this period has been between $3.91 and $13.98 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 1.4 million for the day, a number notably higher than the average daily volume of 0.82 million over the last three months.

EyePoint Pharmaceuticals Inc’s market performance has been stable in recent times. The company’s stock hit a 1-year high of $13.98 on 10/28/24 and a low of $3.91 for the same time frame on 04/09/25.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

EyePoint Pharmaceuticals Inc (EYPT) has experienced a quarterly rise of 137.23% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 754.18M and boasts a workforce of 165 employees.

Analyzing Trading Volume and Moving Average Trends

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for EYPT stands at 0.08. Similarly, the long-term debt-to-equity ratio is also 0.07.

EYPT Stock Price Performance Analysis

Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. This year’s metric has recorded a Price increase of 29.09%. However, over the past six months, we’ve seen a weaker performance of 32.69%. The price of EYPT fallen by 22.60% over the last 30 days. And in the last five days, it has surged by 14.76%.

Invest Chronicle
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.